Aromasin 25 mg (Exemestane TABLET) 25 MG

AROMASIN 25 MG tablets contain exemestane, an aromatase inhibitor used to manage certain conditions in postmenopausal women. This medication is commonly prescribed for hormone receptor-positive breast cancer. AROMASIN 25 MG is manufactured by Pfizer Canada ULC.

Strength

25 MG

Pack Size

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

AROMASIN 25 MG is primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It works by reducing the amount of estrogen produced by the body, which can help slow or stop the growth of certain types of breast cancer cells. This medication is often used as part of a broader treatment plan, including surgery, radiation, or other therapies.

Side Effects

Common effects of AROMASIN 25 MG may include hot flashes, joint pain, fatigue, and nausea. Some users may also experience headaches, insomnia, or mild digestive issues. These effects vary among individuals and are not experienced by everyone taking the medication.

Precautions & Warnings

AROMASIN 25 MG should be handled with care, especially by those with a history of osteoporosis or liver disease. It is important to follow the advice of a healthcare provider regarding its use. Pregnant women or those planning to become pregnant should avoid this medication due to potential risks.

Avoid Interactions

AROMASIN 25 MG may interact with other medications, including certain types of hormonal therapies and drugs that affect liver enzymes. It is advisable to inform a healthcare provider about all current medications before starting AROMASIN 25 MG. Alcohol consumption should be moderated while taking this medication.

References

Frequently Asked Questions

AROMASIN 25 MG is used to treat hormone receptor-positive breast cancer in postmenopausal women by reducing estrogen production.

AROMASIN 25 MG is typically taken orally, once daily, with or without food. Follow the specific instructions provided by a healthcare provider.

Common side effects may include hot flashes, joint pain, fatigue, and nausea. These effects vary among individuals.

AROMASIN 25 MG may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

AROMASIN 25 MG is not recommended for use during pregnancy due to potential risks to the developing fetus.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.